eli lilly tirzepatide patent Semaglutide & Considerations BPI labs is challenging the

Description

Brunners A4PC statement acknowledges that Novo Nordisk holds patents to the drugs, and states that while we arent qualified to offer a legal opinion on the matter, we do note that an exception to the FDA guidance for patented drugs would contradict the very reason the law allows compounding of FDA-approved drugs in shortage in the first place. According to the FDA website, When a drug is in shortage, compounders may be able to prepare a compounded version of that drug if they meet certain requirements in the Federal Food, Drug, and Cosmetic (FD&C) Act

If the drug is an EAP drug and the patient qualifies, include a copy of the EAP approval or denial with your submission

While the trial demonstrated significant weight reduction with retatrutide compared to placebo [11,12], this qualitative exit interview study with trial participants investigated the impact of this weight loss on their lives